Evidence map›Paper›PMID 40758205›Full record

ArticleHuman cell2025

Establishment of Coala: a novel 3D and 2D cancer cell line derived from colorectal cancer liver metastasis.

Sandra Mersakova, Juraj Marcinek, Dusan Brany, Olga Chodelkova, Martin Vorcak, Martin Cermak, Martina Poturnajova, Zuzana Kozovska, Henrieta Skovierova, Slavomira Novakova and 24 more

Abstract read
In one paragraph

Article in Human cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Sandra MersakovaBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Martin, Slovakia.
Juraj MarcinekDepartment of Pathological Anatomy, Jessenius Faculty of Medicine in Martin, and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Dusan BranyBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Martin, Slovakia.
Olga ChodelkovaDepartment of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Martin VorcakClinic of Radiology, Jessenius Faculty of Medicine in Martin, and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Martin CermakDepartment of Genetics, The National Institute of Oncology, Bratislava, Slovakia.
Martina PoturnajovaBiomedical Research Center of Slovak Academy of Sciences, Cancer Research Institute, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Zuzana KozovskaBiomedical Research Center of Slovak Academy of Sciences, Cancer Research Institute, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Henrieta SkovierovaBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Martin, Slovakia.
Slavomira NovakovaBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Martin, Slovakia.
Barbora MitruskovaDepartment of Clinical Genetics, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Dusan LodererBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Martin, Slovakia.
Marian GrendarBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Martin, Slovakia.
Veronika HolubekovaBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Martin, Slovakia.
Andrea HornakovaBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Martin, Slovakia.
Jana MelegovaDepartment of Pathological Physiology and Central Animal Facility, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Mariana BrozmanovaDepartment of Pathological Physiology and Central Animal Facility, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Blazej PalkociClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Martin VojtkoClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Roman KycinaClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Miroslav PinduraClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Jan JanikClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Peter MikolajcikClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Eva GabonovaClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Ludovit LacaClinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Andreas NicodemouGAMMA-ZA, 911 01, Trencin, Slovakia.
Lubos DanisovicInstitute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, 811 08, Bratislava, Slovakia.
Lukas PlankDepartment of Pathological Anatomy, Jessenius Faculty of Medicine in Martin, and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Erika HalasovaBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Martin, Slovakia.
Marek MrazCentral European Institute of Technology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Miroslava MatuskovaBiomedical Research Center of Slovak Academy of Sciences, Cancer Research Institute, Dubravska cesta 9, 845 05, Bratislava, Slovakia.
Zora LasabovaDepartment of Molecular Biology and Genomics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia.
Michal KalmanDepartment of Pathological Anatomy, Jessenius Faculty of Medicine in Martin, and University Hospital Martin, Comenius University in Bratislava, 036 01, Martin, Slovakia. misokalman@gmail.com.
Jan StrnadelBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Martin, Slovakia. jan.strnadel@uniba.sk.ORCID http://orcid.org/0000-0002-7233-6537

Funding

Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR VEGA 2/0170/22Agentúra na Podporu Výskumu a Vývoja APVV-21-0296Agentúra na Podporu Výskumu a Vývoja APVV-21-0372European Regional Development Fund IMTS: 313011V446European Regional Development Fund ITMS: 313011AFG5European Regional Development Fund. ITMS: 313011BWX6Next Generation EU LX22NPO5102
6 · The paper itself

Abstract

Metastatic colorectal cancer is one of the most critical causes of cancer-related dead in patients suffering this type of malignancy. As the liver metastases are found in almost 25-50% of all colorectal cancer patients, there is an urgent need for suitable in vitro and in vivo models. To the best of our knowledge, only a limited number of well-described 2D or 3D organoid/spheroid cell lines originated from human liver metastases was reported for this type of malignancy and submitted to ATCC and other repository centers for general use. Here, we present a novel, well-characterized cell line Coala that was derived directly from liver metastasis of patient with colorectal cancer. Coala cancer cell line was derived by 2D and 3D culture technology and can be, therefore, cultured as standard 2D cell line or as 3D spheroid culture. When transplanted into athymic mice, Coala cell line forms fast growing tumors with histological features similar to original tumor and expressed CDX2, SATB2, and CK20. Whole exome sequencing analysis of Coala cell line showed the presence of pathogenic mutations in C8B, PRKCQ, IRGM, FGFR4, POLR1C, APC and TP53 genes. As verified by antibody array chip analysis, Coala cells express Snail, Pdx-1, FoxA2, and E-cadherin. Our cell line represents a new, well characterized in vitro research tool for cancer research and will be available to researchers in the field via biorepository centers.

Indexed as

Cell Culture TechniquesColorectal NeoplasmsLiver NeoplasmsAnimalsCell Line, TumorHumansMiceMice, NudeMutationSpheroids, Cellular3D cultureCancer cell lineColorectal cancerIn vitro modelsLiver metastasis

Identifiers

PMID40758205
PMCPMC12321644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.